CTN-0117: The Impact of COVID-19 Pandemic on Substance Use Treatment Services

Cynthia Campbell, PhD
Lead Investigator
Research Scientist III
Kaiser Permanente
Cynthia.I.Campbell@kp.org

As a result of the COVID-19 pandemic, we are witnessing profound societal and health system developments with significant implications for the treatment of drug use disorders: an increase in drug use, people of color at disproportionate risk for distress and drug use, and a potentially transformational move to virtual treatment modalities. The proposed study examines this major shift to virtual treatment for drug use disorders during the pandemic in a large, diverse health care system, specifically exploring potential disparities in accessing treatment. Virtual treatment is likely to persist as a major delivery model of alcohol treatment, and understanding potential inequities in access is critical to improving quality of care and outcomes for underserved populations.

    Node Involvement

    Lead Node(s):

  • Health Systems Node

  • All Participating Nodes:

  • Health Systems Node